Today: 16 June 2026
Boeing Stock Debate Widens as Bullish $290 Target Meets Debt, Certification Risk
23 March 2026
2 mins read

Boeing Stock Debate Widens as Bullish $290 Target Meets Debt, Certification Risk

NEW YORK, March 23, 2026, 10:23 EDT

Boeing climbed $4.30 to $199.42 in early U.S. trading Monday. Debates over how to price the stock, though, only got messier. A new TipRanks report highlighted a sharp divide among AI models over Boeing’s outlook—this just days after Yahoo Finance ran a bullish argument and Tigress Financial bumped up its price target. tipranks.com

Why does the split matter now? Boeing needs higher deliveries and a hefty order book to finally drive positive free cash flow—what’s left after capital spending—a big shift after years tangled in safety issues, supply chain snags and production setbacks. Eyes are on certification of the 737 MAX 10 and 777-9; every sign-off pushes up deliveries, pulls in cash, and adds fuel to the recovery story for the stock. Reuters

The three articles each tackle the same underlying tug-of-war, though with different emphases. Thursday brought a bullish argument for Boeing via a Yahoo Finance piece using Insider Monkey as its source. On Friday, Tigress raised its 12-month target from $275 to $290. Then Monday, TipRanks pointed out that even their brighter outlooks left little room for error if Boeing stumbles on execution. Yahoo Finance

Tigress analyst Ivan Feinseth sees Boeing riding a “multi-decade expansion in commercial air traffic” and notes its “growing high-margin aftermarket and digital offerings.” He called out recent numbers as evidence for stronger scale, improved profitability, healthier cash flow and clearer demand trends. tipranks.com

Boeing’s outlook still comes down to execution. Last week, Chief Financial Officer Jay Malave said the company is aiming to boost 737 MAX production to 47 per month “sometime mid-year,” with around 500 deliveries of the jet planned for 2026 and certification for the MAX 7 and MAX 10 still targeted for the second half. Several systems remain to be tested before the Federal Aviation Administration gives its approval, Malave noted. Reuters

Some progress, though no finish line yet. Boeing’s 777-9 has gotten FAA approval to advance into the fourth certification phase as of last week, while Ryanair’s Michael O’Leary said he’s betting on a third-quarter signoff for the 737 MAX 10. That model is Boeing’s pitch against the A321neo from Airbus—a narrow-body jet that’s already built up years of lead time and flight history. Reuters

For the bulls, the numbers speak for themselves. Back in January, Boeing reported a commercial backlog above 6,100 jets, pegged at an all-time high of $567 billion. Reuters noted Boeing pulled ahead of Airbus in net orders for 2025 — something it hasn’t managed in seven years — though Airbus still held the edge in deliveries. Leeham’s Scott Hamilton called the order book a “vote of confidence” for Boeing’s ongoing turnaround. Boeing Investors

The bearish view hasn’t gone anywhere. Boeing last week delayed its commercial airplane unit’s return to profit until 2027. TipRanks, meanwhile, flagged issues like high debt, slim profit margins, lumpy cash flow, and ongoing execution risks in its lower-ranked models. The debt stack stood at $54.1 billion by the end of 2025. Analyst Robert Mann called out engine woes, describing the latest models as “more problematic and inefficient than expected.” Reuters

The mood skews bullish, but with a measure of caution. As of March 12, Reuters stock data showed 29 analysts had Outperform-type calls on Boeing. On Monday, Jefferies’ Sheila Kahyaoglu stuck with her Buy rating and a $295 price target. Boeing shares climbed that day, but what comes next probably depends on certification, deliveries, and any fresh cash-flow color. Reuters

Stock Market Today

  • Dr. Martens CEO Buys 112,500 Shares at £0.761 Each
    June 16, 2026, 3:11 AM EDT. Dr. Martens PLC's CEO Ije Nwokorie bought 112,500 ordinary shares on June 12, 2026, at £0.761 per share on the London Stock Exchange. The purchase, disclosed under UK Market Abuse Regulation rules, signals confidence from the person discharging managerial responsibilities (PDMR). Dr. Martens, known for its iconic 1460 boots, operates globally across retail and wholesale channels. This insider transaction may reflect positive outlook or strategic positioning by the management. The shares have an ISIN of GB00BL6NGV24, representing ordinary shares with a 1 pence nominal value.

Latest articles

Nasdaq steady in late trading as oil eases, Fed up next

Nasdaq steady in late trading as oil eases, Fed up next

16 June 2026
U.S. stocks soared Monday as falling oil prices and a preliminary U.S.-Iran deal fueled a relief rally, with the Nasdaq up 3.07%, S&P 500 up 1.65%, and Dow closing at a record high; after-hours futures dipped slightly as investors awaited Wednesday’s pivotal Federal Reserve decision and Chair Kevin Warsh’s first post-meeting press conference.
Intel stock gains after BofA upgrade, foundry business in focus

Intel Gains as Chip Shares Recover

16 June 2026
Intel surged to $127.86, topping analyst targets, as chip stocks rallied on easing inflation and AI optimism, but the stock’s gains outpace consensus expectations and recent earnings remain negative; investors now await the unconfirmed July 23 earnings report for proof that demand is driving real revenue growth.
Dave & Buster’s falls after Q1 comes up short, comps slip

Dave & Buster’s falls after Q1 comes up short, comps slip

16 June 2026
Dave & Buster’s shares plunged 4.72% to $12.32, then dropped another 11.2% after hours, after Q1 revenue, adjusted profit, and comparable-store sales all missed expectations; management’s guidance for positive sales trends and free-cash-flow remains the next key catalyst as investors weigh the company’s turnaround credibility.
Gold Price Today Falls 5% as Bullion Hits 2026 Low on Rate-Hike Bets
Previous Story

Gold Price Today Falls 5% as Bullion Hits 2026 Low on Rate-Hike Bets

US Stock Market Today: Dow, S&P 500, Nasdaq Surge as Oil Tumbles on Iran Reprieve
Next Story

US Stock Market Today: Dow, S&P 500, Nasdaq Surge as Oil Tumbles on Iran Reprieve

Go toTop